17-alpha-hydroxyprogesterone has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckert, A; Mensah-Nyagan, AG; Patte-Mensah, C; Schaeffer, V | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Alzheimer Disease
| Article | Year |
|---|---|
Making headlines.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Alzheimer Disease; Anxiety; Aortic Aneurysm; Female; Humans; Male; Obstetric Labor, Premature; Papillomaviridae; Pregnancy; Viral Vaccines | 2005 |
Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins.
Topics: 17-alpha-Hydroxyprogesterone; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Androstenediol; Aspartic Acid Endopeptidases; Brain; Cell Shape; Cytoprotection; Endopeptidases; Enzyme Inhibitors; Humans; Mutation; Neurons; Neuroprotective Agents; Peptide Fragments; Progesterone; Steroids; tau Proteins; Testosterone; Transfection; Tumor Cells, Cultured | 2006 |